论文部分内容阅读
颅内出血是急性白血病的常见合并症,并且是重要的死亡原因之一。本组63例占同期住院急性白血病患者的24.9％,占同期死亡病例的52.1％。颅内出血造成死亡多发生在开始化疗后的头二周之内,占42％。直接影响急性白血病的疗效及生存期,一旦确诊,往往没有很好的救治办法,多迅速死亡。故预防颅内出血将成为提高白血病疗效的关键。本文试图通过对63例临床上诊断为颅内出血的急性白血病病例进行分析,寻找颅内出血的危险因素及预防措施。
Intracranial hemorrhage is a common complication of acute leukemia and is one of the important causes of death. The group of 63 cases accounted for 24.9% of hospitalized patients with acute leukemia in the same period, accounting for 52.1% of the deaths in the same period. Intracranial hemorrhage caused more deaths in the first two weeks after starting chemotherapy, accounting for 42%. Directly affect the efficacy and survival of acute leukemia, once diagnosed, often do not have a good treatment, more rapid death. Therefore, prevention of intracranial hemorrhage will become the key to improve the efficacy of leukemia. This article attempts to analyze 63 cases of acute leukemia clinically diagnosed as intracranial hemorrhage to find the risk factors for intracranial hemorrhage and preventive measures.